title: Thrombolytic therapy for massive pulmonary embolism 12 hours after cesarean delivery despite contraindication?
authors.affiliation: Institute of Cardiovascular Diseases, Cardiology Clinic, Clinical Center of Serbia, 11000 Belgrade, Serbia and Montenegro. bstefan@eunet.yu
authors.forename: Branislav S
authors.initials: BS
authors.lastname: Stefanovic
authors.forename: Zorana
authors.initials: Z
authors.lastname: Vasiljevic
authors.forename: Predrag
authors.initials: P
authors.lastname: Mitrovic
authors.forename: Ana
authors.initials: A
authors.lastname: Karadzic
authors.forename: Miodrag
authors.initials: M
authors.lastname: Ostojic
mesh_terms: D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects*; D000075202:Contraindications; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology; D013300:Streptokinase / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase